DOCK5 and head and neck squamous cell carcinoma: DOCK5 has also being implicated in acute myeloid leukemia (Biswas et al., 2019, 30668141), and recently, an oncogenic variant of DOCK5 was described from head and neck squamous cell carcinoma (Liu et al., 2018).